Are Monoclonal Antibodies Still Considered as Innovative by the French Health Care System? A Retrospective Analysis 2000-2012
Nov 1, 2013, 00:00 AM
10.1016/j.jval.2013.08.930
https://www.valueinhealthjournal.com/article/S1098-3015(13)02835-0/fulltext
Section Title :
Health Care Use & Policy Studies
Section Order :
889
First Page :
A483
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(13)02835-0&doi=10.1016/j.jval.2013.08.930